Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation

Por Wachsberger, Phyllis Rachelle, Lawrence, Richard Yaacov, Liu, Yi, Rice, Barbara, Daskalakis, Constantine, Dicker, Adam P.
Publicado em 2013